Incidence and Risk Factors for Perianal Disease in Pediatric Crohn Disease Patients Followed in CEDATA‐GPGE Registry

ABSTRACT Objectives: Perianal disease (PD) with fistula and/or abscess formation is a severe complication in Crohn disease (CD). We examined prevalence, incidence, and risk factors for PD development in a pediatric CD cohort. Methods: Patients with CD from the prospective, multicenter registry for i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pediatric gastroenterology and nutrition 2018-01, Vol.66 (1), p.73-78
Hauptverfasser: Brückner, Annecarin, Werkstetter, Katharina J., Laffolie, Jan, Wendt, Claudia, Prell, Christine, Weidenhausen, Tanja, Zimmer, Klaus P., Koletzko, Sibylle
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 78
container_issue 1
container_start_page 73
container_title Journal of pediatric gastroenterology and nutrition
container_volume 66
creator Brückner, Annecarin
Werkstetter, Katharina J.
Laffolie, Jan
Wendt, Claudia
Prell, Christine
Weidenhausen, Tanja
Zimmer, Klaus P.
Koletzko, Sibylle
description ABSTRACT Objectives: Perianal disease (PD) with fistula and/or abscess formation is a severe complication in Crohn disease (CD). We examined prevalence, incidence, and risk factors for PD development in a pediatric CD cohort. Methods: Patients with CD from the prospective, multicenter registry for inflammatory bowel disease from Germany and Austria (CEDATA‐GPGE) were included if diagnosed at the age of 18 years or younger, registered within 3 months after diagnosis, and having at least 2 follow‐up visits within the first year of registration. We examined potential risk factors for PD with Kaplan‐Meier analysis and a final Cox model considering sex, family history of inflammatory bowel disease, extraintestinal manifestations, disease location, and induction therapy (corticosteroids or nutritional therapy). Results: Of 2406 patients with CD, 742 fulfilled inclusion criteria (59% boys, mean age at diagnosis 12.4 ± 3.4 years). PD was present at diagnosis in 41 patients (5.5%; 80.9% boys), whereas 32 patients (4.3%, 81.3% male) developed PD during follow‐up (mean 2.0 ± 1.6 years). The cumulative incidence of PD at 12 and 36 months after diagnosis was 3.5% and 7.5%, respectively. Potential risk factors for PD development during follow‐up were male sex (hazard ratio = 3.2, [95%; confidence interval 1.2–7.8]) and induction therapy with corticosteroids (hazard ratio = 2.5 [1.1–5.5]). Diagnostic evaluation at PD diagnosis was incomplete in 40% of affected subjects. PD resolved within 1 year in 50% of cases. Conclusions: Approximately 10% of CD patients in our cohort suffered from PD within the first 3 years of their disease. Male sex and initial corticosteroid therapy were associated with an increased risk to develop PD after diagnosis.
doi_str_mv 10.1097/MPG.0000000000001649
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1908796485</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1908796485</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5229-fecef65a65d6e8fc9e86aefad04a364f93e2eaaeb2e524c5b58db639f21d6c9a3</originalsourceid><addsrcrecordid>eNqNkMFuEzEQhi0EoqHwBgj5yGWL7bW96wOHkCahqMCqKmfLscfE1FkXe0OUG4_AM_IkbJVQIS4wl5Fmvv-f0Y_Qc0rOKFHNq_fd8oz8UVRy9QBNqKhlxVtCH6IJYU1TMUrlCXpSypcRarggj9EJayXhgtIJ-nbR2-Cgt4BN7_BVKDd4YeyQcsE-ZdxBDqY3EZ-HAqYADv04c8EMOVg8y2nd3686MwToh4IXKca0A3cHz-bn0-vpz-8_lt1yjq_gcyhD3j9Fj7yJBZ4d-yn6tJhfz95Wlx-XF7PpZWUFY6ryYMFLYaRwElpvFbTSgDeOcFNL7lUNDIyBFQPBuBUr0bqVrJVn1EmrTH2KXh58b3P6uoUy6E0oFmI0PaRt0VSRtlGSt2JE-QG1OZWSwevbHDYm7zUl-i5xPSau_058lL04XtiuNuDuRb8jHoH2AOxSHCCXm7jdQdZrMHFY_8v79VEaIuz_6x_9rvtQv1kQohitfwGNnZ_f</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1908796485</pqid></control><display><type>article</type><title>Incidence and Risk Factors for Perianal Disease in Pediatric Crohn Disease Patients Followed in CEDATA‐GPGE Registry</title><source>Journals@Ovid Complete</source><source>Access via Wiley Online Library</source><creator>Brückner, Annecarin ; Werkstetter, Katharina J. ; Laffolie, Jan ; Wendt, Claudia ; Prell, Christine ; Weidenhausen, Tanja ; Zimmer, Klaus P. ; Koletzko, Sibylle</creator><creatorcontrib>Brückner, Annecarin ; Werkstetter, Katharina J. ; Laffolie, Jan ; Wendt, Claudia ; Prell, Christine ; Weidenhausen, Tanja ; Zimmer, Klaus P. ; Koletzko, Sibylle ; CEDATA-GPGE study group ; CEDATA‐GPGE study group</creatorcontrib><description>ABSTRACT Objectives: Perianal disease (PD) with fistula and/or abscess formation is a severe complication in Crohn disease (CD). We examined prevalence, incidence, and risk factors for PD development in a pediatric CD cohort. Methods: Patients with CD from the prospective, multicenter registry for inflammatory bowel disease from Germany and Austria (CEDATA‐GPGE) were included if diagnosed at the age of 18 years or younger, registered within 3 months after diagnosis, and having at least 2 follow‐up visits within the first year of registration. We examined potential risk factors for PD with Kaplan‐Meier analysis and a final Cox model considering sex, family history of inflammatory bowel disease, extraintestinal manifestations, disease location, and induction therapy (corticosteroids or nutritional therapy). Results: Of 2406 patients with CD, 742 fulfilled inclusion criteria (59% boys, mean age at diagnosis 12.4 ± 3.4 years). PD was present at diagnosis in 41 patients (5.5%; 80.9% boys), whereas 32 patients (4.3%, 81.3% male) developed PD during follow‐up (mean 2.0 ± 1.6 years). The cumulative incidence of PD at 12 and 36 months after diagnosis was 3.5% and 7.5%, respectively. Potential risk factors for PD development during follow‐up were male sex (hazard ratio = 3.2, [95%; confidence interval 1.2–7.8]) and induction therapy with corticosteroids (hazard ratio = 2.5 [1.1–5.5]). Diagnostic evaluation at PD diagnosis was incomplete in 40% of affected subjects. PD resolved within 1 year in 50% of cases. Conclusions: Approximately 10% of CD patients in our cohort suffered from PD within the first 3 years of their disease. Male sex and initial corticosteroid therapy were associated with an increased risk to develop PD after diagnosis.</description><identifier>ISSN: 0277-2116</identifier><identifier>EISSN: 1536-4801</identifier><identifier>DOI: 10.1097/MPG.0000000000001649</identifier><identifier>PMID: 28604511</identifier><language>eng</language><publisher>United States: by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology</publisher><subject>abscess ; corticosteroids ; incidence ; perianal disease ; prevalence</subject><ispartof>Journal of pediatric gastroenterology and nutrition, 2018-01, Vol.66 (1), p.73-78</ispartof><rights>2018 by European Society for European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition</rights><rights>2018 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5229-fecef65a65d6e8fc9e86aefad04a364f93e2eaaeb2e524c5b58db639f21d6c9a3</citedby><cites>FETCH-LOGICAL-c5229-fecef65a65d6e8fc9e86aefad04a364f93e2eaaeb2e524c5b58db639f21d6c9a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1097%2FMPG.0000000000001649$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1097%2FMPG.0000000000001649$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27933,27934,45583,45584</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28604511$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brückner, Annecarin</creatorcontrib><creatorcontrib>Werkstetter, Katharina J.</creatorcontrib><creatorcontrib>Laffolie, Jan</creatorcontrib><creatorcontrib>Wendt, Claudia</creatorcontrib><creatorcontrib>Prell, Christine</creatorcontrib><creatorcontrib>Weidenhausen, Tanja</creatorcontrib><creatorcontrib>Zimmer, Klaus P.</creatorcontrib><creatorcontrib>Koletzko, Sibylle</creatorcontrib><creatorcontrib>CEDATA-GPGE study group</creatorcontrib><creatorcontrib>CEDATA‐GPGE study group</creatorcontrib><title>Incidence and Risk Factors for Perianal Disease in Pediatric Crohn Disease Patients Followed in CEDATA‐GPGE Registry</title><title>Journal of pediatric gastroenterology and nutrition</title><addtitle>J Pediatr Gastroenterol Nutr</addtitle><description>ABSTRACT Objectives: Perianal disease (PD) with fistula and/or abscess formation is a severe complication in Crohn disease (CD). We examined prevalence, incidence, and risk factors for PD development in a pediatric CD cohort. Methods: Patients with CD from the prospective, multicenter registry for inflammatory bowel disease from Germany and Austria (CEDATA‐GPGE) were included if diagnosed at the age of 18 years or younger, registered within 3 months after diagnosis, and having at least 2 follow‐up visits within the first year of registration. We examined potential risk factors for PD with Kaplan‐Meier analysis and a final Cox model considering sex, family history of inflammatory bowel disease, extraintestinal manifestations, disease location, and induction therapy (corticosteroids or nutritional therapy). Results: Of 2406 patients with CD, 742 fulfilled inclusion criteria (59% boys, mean age at diagnosis 12.4 ± 3.4 years). PD was present at diagnosis in 41 patients (5.5%; 80.9% boys), whereas 32 patients (4.3%, 81.3% male) developed PD during follow‐up (mean 2.0 ± 1.6 years). The cumulative incidence of PD at 12 and 36 months after diagnosis was 3.5% and 7.5%, respectively. Potential risk factors for PD development during follow‐up were male sex (hazard ratio = 3.2, [95%; confidence interval 1.2–7.8]) and induction therapy with corticosteroids (hazard ratio = 2.5 [1.1–5.5]). Diagnostic evaluation at PD diagnosis was incomplete in 40% of affected subjects. PD resolved within 1 year in 50% of cases. Conclusions: Approximately 10% of CD patients in our cohort suffered from PD within the first 3 years of their disease. Male sex and initial corticosteroid therapy were associated with an increased risk to develop PD after diagnosis.</description><subject>abscess</subject><subject>corticosteroids</subject><subject>incidence</subject><subject>perianal disease</subject><subject>prevalence</subject><issn>0277-2116</issn><issn>1536-4801</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNqNkMFuEzEQhi0EoqHwBgj5yGWL7bW96wOHkCahqMCqKmfLscfE1FkXe0OUG4_AM_IkbJVQIS4wl5Fmvv-f0Y_Qc0rOKFHNq_fd8oz8UVRy9QBNqKhlxVtCH6IJYU1TMUrlCXpSypcRarggj9EJayXhgtIJ-nbR2-Cgt4BN7_BVKDd4YeyQcsE-ZdxBDqY3EZ-HAqYADv04c8EMOVg8y2nd3686MwToh4IXKca0A3cHz-bn0-vpz-8_lt1yjq_gcyhD3j9Fj7yJBZ4d-yn6tJhfz95Wlx-XF7PpZWUFY6ryYMFLYaRwElpvFbTSgDeOcFNL7lUNDIyBFQPBuBUr0bqVrJVn1EmrTH2KXh58b3P6uoUy6E0oFmI0PaRt0VSRtlGSt2JE-QG1OZWSwevbHDYm7zUl-i5xPSau_058lL04XtiuNuDuRb8jHoH2AOxSHCCXm7jdQdZrMHFY_8v79VEaIuz_6x_9rvtQv1kQohitfwGNnZ_f</recordid><startdate>201801</startdate><enddate>201801</enddate><creator>Brückner, Annecarin</creator><creator>Werkstetter, Katharina J.</creator><creator>Laffolie, Jan</creator><creator>Wendt, Claudia</creator><creator>Prell, Christine</creator><creator>Weidenhausen, Tanja</creator><creator>Zimmer, Klaus P.</creator><creator>Koletzko, Sibylle</creator><general>by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201801</creationdate><title>Incidence and Risk Factors for Perianal Disease in Pediatric Crohn Disease Patients Followed in CEDATA‐GPGE Registry</title><author>Brückner, Annecarin ; Werkstetter, Katharina J. ; Laffolie, Jan ; Wendt, Claudia ; Prell, Christine ; Weidenhausen, Tanja ; Zimmer, Klaus P. ; Koletzko, Sibylle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5229-fecef65a65d6e8fc9e86aefad04a364f93e2eaaeb2e524c5b58db639f21d6c9a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>abscess</topic><topic>corticosteroids</topic><topic>incidence</topic><topic>perianal disease</topic><topic>prevalence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brückner, Annecarin</creatorcontrib><creatorcontrib>Werkstetter, Katharina J.</creatorcontrib><creatorcontrib>Laffolie, Jan</creatorcontrib><creatorcontrib>Wendt, Claudia</creatorcontrib><creatorcontrib>Prell, Christine</creatorcontrib><creatorcontrib>Weidenhausen, Tanja</creatorcontrib><creatorcontrib>Zimmer, Klaus P.</creatorcontrib><creatorcontrib>Koletzko, Sibylle</creatorcontrib><creatorcontrib>CEDATA-GPGE study group</creatorcontrib><creatorcontrib>CEDATA‐GPGE study group</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pediatric gastroenterology and nutrition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brückner, Annecarin</au><au>Werkstetter, Katharina J.</au><au>Laffolie, Jan</au><au>Wendt, Claudia</au><au>Prell, Christine</au><au>Weidenhausen, Tanja</au><au>Zimmer, Klaus P.</au><au>Koletzko, Sibylle</au><aucorp>CEDATA-GPGE study group</aucorp><aucorp>CEDATA‐GPGE study group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incidence and Risk Factors for Perianal Disease in Pediatric Crohn Disease Patients Followed in CEDATA‐GPGE Registry</atitle><jtitle>Journal of pediatric gastroenterology and nutrition</jtitle><addtitle>J Pediatr Gastroenterol Nutr</addtitle><date>2018-01</date><risdate>2018</risdate><volume>66</volume><issue>1</issue><spage>73</spage><epage>78</epage><pages>73-78</pages><issn>0277-2116</issn><eissn>1536-4801</eissn><abstract>ABSTRACT Objectives: Perianal disease (PD) with fistula and/or abscess formation is a severe complication in Crohn disease (CD). We examined prevalence, incidence, and risk factors for PD development in a pediatric CD cohort. Methods: Patients with CD from the prospective, multicenter registry for inflammatory bowel disease from Germany and Austria (CEDATA‐GPGE) were included if diagnosed at the age of 18 years or younger, registered within 3 months after diagnosis, and having at least 2 follow‐up visits within the first year of registration. We examined potential risk factors for PD with Kaplan‐Meier analysis and a final Cox model considering sex, family history of inflammatory bowel disease, extraintestinal manifestations, disease location, and induction therapy (corticosteroids or nutritional therapy). Results: Of 2406 patients with CD, 742 fulfilled inclusion criteria (59% boys, mean age at diagnosis 12.4 ± 3.4 years). PD was present at diagnosis in 41 patients (5.5%; 80.9% boys), whereas 32 patients (4.3%, 81.3% male) developed PD during follow‐up (mean 2.0 ± 1.6 years). The cumulative incidence of PD at 12 and 36 months after diagnosis was 3.5% and 7.5%, respectively. Potential risk factors for PD development during follow‐up were male sex (hazard ratio = 3.2, [95%; confidence interval 1.2–7.8]) and induction therapy with corticosteroids (hazard ratio = 2.5 [1.1–5.5]). Diagnostic evaluation at PD diagnosis was incomplete in 40% of affected subjects. PD resolved within 1 year in 50% of cases. Conclusions: Approximately 10% of CD patients in our cohort suffered from PD within the first 3 years of their disease. Male sex and initial corticosteroid therapy were associated with an increased risk to develop PD after diagnosis.</abstract><cop>United States</cop><pub>by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology</pub><pmid>28604511</pmid><doi>10.1097/MPG.0000000000001649</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0277-2116
ispartof Journal of pediatric gastroenterology and nutrition, 2018-01, Vol.66 (1), p.73-78
issn 0277-2116
1536-4801
language eng
recordid cdi_proquest_miscellaneous_1908796485
source Journals@Ovid Complete; Access via Wiley Online Library
subjects abscess
corticosteroids
incidence
perianal disease
prevalence
title Incidence and Risk Factors for Perianal Disease in Pediatric Crohn Disease Patients Followed in CEDATA‐GPGE Registry
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-02T05%3A50%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incidence%20and%20Risk%20Factors%20for%20Perianal%20Disease%20in%20Pediatric%20Crohn%20Disease%20Patients%20Followed%20in%20CEDATA%E2%80%90GPGE%20Registry&rft.jtitle=Journal%20of%20pediatric%20gastroenterology%20and%20nutrition&rft.au=Br%C3%BCckner,%20Annecarin&rft.aucorp=CEDATA-GPGE%20study%20group&rft.date=2018-01&rft.volume=66&rft.issue=1&rft.spage=73&rft.epage=78&rft.pages=73-78&rft.issn=0277-2116&rft.eissn=1536-4801&rft_id=info:doi/10.1097/MPG.0000000000001649&rft_dat=%3Cproquest_cross%3E1908796485%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1908796485&rft_id=info:pmid/28604511&rfr_iscdi=true